secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0001641172-25-002818
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma shareholders approve issuance of up to 16.9M shares and ratify auditor
--------------------------------------------------------------------------------

- Proposal 1 passed with 88% of votes cast; authorizes up to 16,894,212 common shares upon conversion of Series C Preferred and warrants.
- Proposal 2 ratified EisnerAmper LLP as independent auditor for FY2025 with 95% of votes cast.
- Proposal 3 to adjourn meeting if needed approved with 90% of votes cast.
- Shareholders representing 52.47% of outstanding shares were present at the Special Meeting on April 4, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225002818/0001641172-25-002818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225002818/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer